Opportunities for accelerating innovation and mitigating risk at the nexus of IP and R&D
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Sponsored content

Opportunities for accelerating innovation and mitigating risk at the nexus of IP and R&D

Sponsored by

Logo 22.07.22.png
Vector circle tech with light blue and lamp bulb on technology b

The CAS IP Research Team analyse how organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation

The transformation of IP management within commercial companies is driving the adoption of new practices and technologies to more closely align IP objectives with growth strategies, unlock greater portfolio value, and support strategic decision-making across enterprises.

This research white paper from CAS explores this transformation at the nexus of IP and research and development (R&D), where organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation earlier in the product lifecycle.

Missing critical IP information during R&D can lead to misallocated resources, potential patent entanglements downstream, and delays in commercialisation. The white paper provides valuable insights for R&D and IP managers about these critical topics:

  • Top IP management goals over the next 12 months;

  • Role and use of IP information across organisations;

  • Challenges in using IP information; 

  • State of IP information access and investments; and 

  • Resolving IP information gaps 

Click here to access CAS’s white paper – “Opportunities for Accelerating Innovation and Mitigating Risk at the Nexus of Intellectual Property and R&D”

Click here to access CAS’s content hub on Managing IP

more from across site and ros bottom lb

More from across our site

The former head of life sciences at Kramer Levin has joined Orrick, a firm that hopes to grow in the sector
Lionel Martin of August Debouzy and Kristof Neefs at Inteo share how they prevailed in a UPC Court of Appeal case surrounding access to documents
Counsel say ‘strange’ results have increased their reliance on subscription-based search platforms, but costs are not being shifted onto clients yet
The firm was among multiple winners at a record-breaking 2024 ceremony held in London on April 11
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
The Americas research cycle has commenced. Do not miss this opportunity to nominate your work!
Increased and new patent fees could affect prosecution strategies for law firms and companies, according to sources
Five former Oblon lawyers felt that joining Merchant & Gould would help them offer the right prices to entice clients
The UK may not be a UPC member but its firms are still acting in proceedings, with Carpmaels among the most prominent
Naomi Pearce of Pearce IP shares how she is helping her firm become a life sciences leader and how generous policies have helped attract top talent
Gift this article